Getting Around Dopamine, But Getting at Parkinson's
By Anette Breindl
Thursday, January 26, 2012
Scientists at the University of California at San Francisco identified a protein that could be a drug target for treating Parkinson's disease, a neurodegenerative disorder that affects more than 10 million people worldwide.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.